regulations
July 27, 2021

CBD Global Sciences Management Cease Trade Order (MCTO) Revoked by the Alberta Securities Commission

CBD Global Sciences, Inc. acknowledges the Cease Trade Order (CTO) issued by the Alberta Securities Commission on 7/23/21. This past Friday the Alberta Securities Commission revoked a MCTO and issued a CTO to the company ceasing all trading of the security until financials are filed for the year end 2020. […]
July 5, 2021

CBD Global Issues Fourth Bi-Weekly Status Report Regarding Management Cease Trade Order

CBD Global Sciences Inc. (CSE: CBDN) (the “Corporation“) further to its press releases dated May 14, 2021, May 28, 2021, and June 15, 2021, provides this fourth bi-weekly default status report in accordance with National Policy 12-203 – Cease Trade Orders for Continuous Disclosure Defaults (“NP 12-203”). In the Corporation’s initial default […]
June 15, 2021

CBD Global Issues Third Bi-Weekly Status Report Regarding Management Cease Trade Order

CBD Global Sciences Inc. further to its press releases dated May 14, 2021, and May 28, 2021 provides this third bi-weekly default status report in accordance with National Policy 12-203 – Cease Trade Orders for Continuous Disclosure Defaults (“NP 12-203”). In the Corporation’s initial default announcement of April 14, 2021 (the “Default Notice”), […]
April 14, 2021

CBD Global Announces Delayed Filing of Annual Financial Statements and MD&A and Application for Management Cease Trade Order

CBD Global Sciences Inc. would like to provide an update on the status of the filing of its annual financial statements, accompanying management’s discussion and analysis and related CEO and CFO certifications for the year ended December 31, 2020 (collectively, the “Annual Filings“). Due to the continued impact of COVID-19, […]
November 25, 2019

Global Sciences Achieves Listing on The Frankfurt Stock Exchange

CBD Global Sciences, Inc. today announced that its common shares have been listed on the Frankfurt Stock Exchange under the symbol “GS3.” The Company’s common shares continue to be listed on the Canadian Securities Exchange under the symbol “CBDN.” Brad Wyatt, CEO of the Company, commented, “we are excited to […]
October 28, 2019

Global Sciences Announces Listing on the Canadian Securities Exchange

 CBD Global Sciences Inc. is pleased to announce that the Company has completed the merger of Global NV Corp. (“GNV”), a wholly owned subsidiary of the Company (“Subco”) whereby the Company acquired all of the outstanding securities of GNV by way of a plan of merger pursuant to the laws […]